Business / Finance

RSS

Linden acquires Young Innovations

Young Innovations, Inc. today announced the completion of its acquisition by affiliates of Linden Capital Partners in an all-cash transaction valued at approximately $314 million.

31 Jan 2013

McKesson third quarter revenues increase 1% to $31.2 billion

McKesson Corporation today reported that revenues for the third quarter ended December 31, 2012 were $31.2 billion, up 1% compared to $30.8 billion a year ago. On the basis of U.S. generally accepted accounting principles, third-quarter earnings per diluted share was $1.24 compared to $1.20 a year ago.

31 Jan 2013

Oclaro second quarter revenues increase to $159.5 million

Oclaro, Inc., a provider of optical components, modules and subsystems, today announced the financial results for its second quarter of fiscal year 2013, which ended December 29, 2012.

31 Jan 2013

Abaxis third quarter revenues increase 32% to $49.8 million

Abaxis, Inc., a medical products company manufacturing point-of-care blood analysis systems, today reported financial results for the third fiscal quarter ended December 31, 2012.

31 Jan 2013

Zimmer fourth quarter net sales increase to $1.18 billion

Zimmer Holdings, Inc. today reported financial results for the quarter and year ended December 31, 2012. The Company reported fourth quarter net sales of $1.18 billion, an increase of 1.1% reported and 2.1% constant currency over the fourth quarter of 2011.

31 Jan 2013

Teva terminates collaboration with CureTech

Teva Pharmaceutical Industries Ltd. announced today the termination of its collaboration with CureTech Ltd.

31 Jan 2013

Texas College of Traditional Chinese Medicine announces change of name

Texas College of Traditional Chinese Medicine announces the change of its name to Texas Health and Science University. "Our name change means another giant step to move the school's global efforts to work with more universities and implement our strategic initiatives!" says Lisa Ping Hui Lin, E.M.B.A., President and Chief Executive Officer.

31 Jan 2013

Keryx prices underwritten public offering of common stock

Keryx Biopharmaceuticals, Inc. today announced the pricing of its previously announced underwritten public offering of common stock consisting of 8,234,000 shares at $8.49 per share.

30 Jan 2013

Foresee, ScinoPharm to form joint venture for new oncological Leuprolide injectable drug

ScinoPharm and Foresee Pharmaceuticals, Inc. jointly announced today that an investment agreement to form a joint venture has been signed. This venture looks to develop a series of peptide injectable drugs with the first being a new oncological Leuprolide injectable drug product, where Leuprolide will be formulated in a proprietary controlled-release drug delivery system originally developed by Foresee and transferred to the joint venture.

30 Jan 2013

Glenmark third quarter consolidated revenue increases 33.96% to Rs. 13812.59M

Glenmark Pharmaceuticals Limited (GPL), the research-led global integrated pharmaceutical company announced its results for the third quarter ended December 31, 2012.

30 Jan 2013

Health industry shows stock market muscle

Despite various concerns and challenges, health care stocks, including shares of for-profit hospitals, have fared well in the opening weeks of 2013.

29 Jan 2013

Examining benefits of vaccine investment

Writing in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Joe Cerrell, director of the foundation's Europe office, and David Ferreira, managing director for innovative finance and head of the Washington, D.C., office at the GAVI Alliance, examine the benefits of investing in vaccines, stating, "Funding and supporting the delivery of life-saving vaccines is one proven way that the private sector can obtain measurable, long-term, and extremely cost-effective results."

28 Jan 2013

Transcat acquires Cal-Matrix

Transcat, Inc., a leading distributor of professional grade handheld test, measurement and control instruments and accredited provider of calibration, repair, inspection and other compliance services, announced today that it has acquired Cal-Matrix Metrology Inc., a leading Canadian provider of commercial and accredited calibrations and coordinate measurement inspection services.

28 Jan 2013

Toshiba enters agreement to acquire majority shares of TMST

Toshiba Medical Systems Corporation, a group company of Toshiba Corporation, today announced that it has entered into an agreement to acquire a majority shares of the stock of a distributor in Turkey, TMST Tıbbi Sistemler Pazarlama Ticaret ve Servis A.S. handling medical diagnostic imaging systems sales and services of TMSC products in Turkish market.

28 Jan 2013

Covidien first quarter sales increase 5% to $3.06 billion

Covidien plc today reported results for the first quarter of fiscal 2013 (October - December 2012). First-quarter net sales of $3.06 billion were 5% above the $2.90 billion reported in the comparable period a year ago. Foreign exchange rate movement lowered the quarterly sales growth rate by one percentage point.

25 Jan 2013

'Big Push' campaign revived at World Economic summit

"Last September the Huffington Post, together with the Global Fund [to Fight AIDS, Tuberculosis and Malaria], launched 'The Big Push' campaign, seeking to build on the great progress that has been made in recent years fighting AIDS, tuberculosis, and malaria."

24 Jan 2013

Inspiration, Ipsen and Baxter enter Asset Purchase Agreement for OBI-1

Ipsen and Inspiration Biopharmaceuticals Inc. today announced they entered into an Asset Purchase Agreement (APA) whereby Baxter International (Baxter) agrees to acquire the worldwide rights to OBI-1, a recombinant porcine factor VIII (rpFVIII) in development for congenital hemophilia A with inhibitors and acquired hemophilia A, and Ipsen's industrial facility in Milford (Boston, MA).

24 Jan 2013

PathCentral announces roll-out of new pathology network

PathCentral, a technology-enabled company dedicated to the success of the international pathology community, and China-based Kindstar Globalgene Technology, Inc., today announced the roll-out of the PathCentral Pathology Network, an online professional pathology network that will enable Kindstar to access US pathologists and facilitate pathology consultations for more than 3,300 hospitals throughout China.

22 Jan 2013

Simcere enters share transfer agreement with Devont Asset Management

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today announced that the Company entered into a share transfer agreement with Devont Asset Management Limited on January 15th 2013 to sell an approximately 35% equity interest in Shanghai Celgen Bio-Pharmaceutical Co., Ltd. for a cash consideration of RMB 302 million.

22 Jan 2013

DaVita forms joint venture with Riches Healthcare

DaVita, the kidney care division of DaVita HealthCare Partners Inc. and a leading provider of kidney care services, today announced the formation of a joint venture with Riches Healthcare (RHC), through which a new entity - DaVita Taiwan - will provide services to four dialysis clinics. DaVita will own a majority share of the joint venture entity.

21 Jan 2013